Rapid blood test device for HIV, HBV, HCV, & syphillis
Malaysian Health Technology Assessment (MaHTAS)
Record ID 32016000287
English
Authors' objectives:
To assess the effectiveness, safety and cost-effectiveness of the rapid blood test device (BPC Labmen 4 in 1 RDT) for HIV, HBV, HCV, & Syphillis for the rapid diagnosis of human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), and syphillis.
Authors' recommendations:
There was no retrievable scientific evidence or clinical studies to support the efficacy / effectiveness, safety and cost effectiveness of this rapid blood test device (BPC Labmen 4 in 1 RDT) for HIV, HBV, HCV, & Syphillis for the rapid diagnosis of human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), and syphillis.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.moh.gov.my/index.php/database_stores/store_view_page/30/255
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Malaysia
MeSH Terms
- Humans
- HIV Infections
- Hematologic Tests
- Hepatitis B
- Hepatitis C
Contact
Organisation Name:
Malaysian Health Technology Assessment
Contact Address:
Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229
Contact Name:
htamalaysia@moh.gov.my
Contact Email:
htamalaysia@moh.gov.my
Copyright:
Malaysian Health Technology Assessment (MaHTAS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.